Mirum Pharmaceuticals Inc (MIRM) earnings · rev $521.3M
These earnings events as JSON? API free 100/dayMirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
This MIRM earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported MIRM revenue for 2025-12-31 was $521.3M. Net income was -$23.4M. Revenue was up 54.7% from 2024-12-31 to 2025-12-31. MIRM currently screens at market cap $6.22B.
When the next MIRM 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 54.7% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full MIRM research stays on the stock page; the tape stays on the quote page.
MIRM earnings FAQ
What are MIRM's latest revenue and net income?
Latest cached Mirum Pharmaceuticals Inc (MIRM) revenue for Dec 31, 2025 was $521.3M. Net income was -$23.4M. Statements: https://lician.com/financials/mirm
What is MIRM's latest diluted EPS?
Latest cached Mirum Pharmaceuticals Inc (MIRM) diluted EPS for Dec 31, 2025 was -$0.47.
What period does the latest MIRM earnings print cover?
The latest cached Mirum Pharmaceuticals Inc (MIRM) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did MIRM revenue change from the prior cached period?
Cached Mirum Pharmaceuticals Inc (MIRM) revenue was up 54.7% from $336.9M (Dec 31, 2024) to $521.3M (Dec 31, 2025). Statements: https://lician.com/financials/mirm
Where are MIRM earnings listed?
Cached earnings facts for Mirum Pharmaceuticals Inc (MIRM) are listed at https://lician.com/earnings/mirm. Statements: https://lician.com/financials/mirm
Not investment advice.